Respond by suggesting additional patient factors that might have interfered with the pharmacokinetic and pharmacodynamic processes of the patients they described. In addition, suggest how the personalized plan of care might change if the age of the patient were different and/or if the patient had a comorbid condition, such as renal failure, heart failure, or liver failure.

Pharmacokinetics and Pharmacodynamics

Name

Institutional Affiliation

Factors that might have interfered with the pharmacokinetic and pharmacodynamics processes of the patient

There may be some additional factors that might have interfered with the pharmacokinetics and pharmacodynamics processes of the 48-year-old Caucasian patient. She was in the ICU after being found unresponsive from an apparent drug overdose. One of the factors may include early life exposure to certain agents, which could have had an impact on her neurological function.  Her system may have been unable to clear the therapeutic drugs and chemicals, therefore interfering with her pharmacokinetics and pharmacodynamics processes (Alomar, 2014).

Another possible factor includes a likelihood of liver and kidney diseases, which can lead to a decrease in the clearance function of the organs, which are vital for the absorption of the medication.  Other factors that could have led to adverse drug reactions include her intake of alcohol and other drugs, which could have an impact on her response to the drugs.  Age, her race, gender, and drug dose and frequency are also some of the other underlying factors that could have resulted in her reaction to the medication (Weerink et al., 2017).  Taking these factors into consideration during her medical evaluation could, therefore, enable a caregiver or a medical practitioner to choose the best drug regimen.

A personalized plan of care

Hence, there is a need to consider all these factors before giving any medication to the patient as a way of avoiding her reaction.  Some of these factors can be changed, such as alcohol and smoking.  However, the presence of genetic factors or diseases cannot be altered (Holford, 2020). The drugs administered must hence ensure that they do not cause worse reactions to the patient.  Understanding these factors can enable a health professional to have a well-programmed medication for this patient and offer help with the most suitable decisions on drug selection.

References

Alomar, M. (2014). Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J., 22(2):83‐94. doi:10.1016/j.jsps.2013.02.003

Holford, N. H. (2020). Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action. Retrieved from https://accessmedicine.mhmedical.com/content.aspx?bookid=2249&sectionid=175215748

Weerink, M. A., Struys, M. M., Hannivoort, L. N., Barends, C. R., Absalom, A. R., & Colin, P. (2017). Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clinical pharmacokinetics. 56(8), 893-913.